No abstract available
Keywords:
Arrhythmia; Catecholaminergic polymorphic ventricular tachycardia; Flecainide; Side effects; Treatment; β-blockers.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists* / administration & dosage
-
Adrenergic beta-Antagonists* / adverse effects
-
Adult
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / adverse effects
-
Dose-Response Relationship, Drug
-
Drug Monitoring
-
Drug Substitution / methods
-
Drug Tolerance
-
Electrocardiography / methods
-
Flecainide* / administration & dosage
-
Flecainide* / adverse effects
-
Humans
-
Medication Therapy Management
-
Patient Selection
-
Tachycardia, Ventricular / diagnosis
-
Tachycardia, Ventricular / drug therapy*
-
Tachycardia, Ventricular / physiopathology
-
Treatment Outcome
-
Voltage-Gated Sodium Channel Blockers / administration & dosage
-
Voltage-Gated Sodium Channel Blockers / adverse effects
Substances
-
Adrenergic beta-Antagonists
-
Anti-Arrhythmia Agents
-
Voltage-Gated Sodium Channel Blockers
-
Flecainide
Supplementary concepts
-
Polymorphic catecholergic ventricular tachycardia